New AI model predicts gut microbial load, revealing its role in health and disease

Including microbial load in microbiota studies can help researchers better understand how gut bacteria influence diseases, leading to more accurate diagnoses and effective treatments.

Tailored dietary strategies may boost remission for Crohn’s disease

The findings highlight the importance of maintaining a healthy microbiota after EEN and suggest that personalized dietary approaches can help induce remission for children with Crohn’s disease.

Integrating microbiome data into food safety: EFSA’s approach to risk assessment in the agri-food chain

Konstantinos Paraskevopoulos (European Food Security Autority, EFSA) underscores the importance of microbiome data in assessing the safety of food and feed products across the agri-food chain.

Study links gut bacteria to Alzheimer’s, uncovering potential new targets

The findings suggest that gut microbes and LPC are potential therapeutic targets for Alzheimer's disease.

New virus-like agents identified in human gut and oral microbiotas

Researchers have identified a new class of virus-like agents known as "obelisks" in oral and stool samples from hundred of people.

The double-edged sword of dietary fiber: tailoring fiber intake for gut health in autoimmune conditions

Heather Armstrong, from University of Manitoba and University of Alberta (Canada), explores the intricate role of dietary fibers in maintaining gut health, focusing on the microbiome’s ability to process these…

Tumor microbiome, immunity, and prognosis: a comprehensive atlas

This article presents “The Cancer Microbiota Database," an interactive and customizable tool to investigate 33 types of cancers.

Specific gut metabolites may help diagnose endometriosis

The findings suggest that 4-hydroxyindole could be a promising biomarker for diagnosing endometriosis.

Personalized nutrition in a changing world: addressing global health challenges with lifestyle medicine and omics

Hellas Cena, from University of Pavia (Italy), emphasizes the growing importance of nutrition in addressing current global health challenges.

MaaT Pharma reports positive Phase 1b results for MaaT033 in ALS, setting the stage for future advances

A significant milestone for both microbiome research and neurodegenerative diseases.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top